TargetID

TargetID is an AI-powered drug target identification and validation suite developed by Lifebit, designed for researchers and life sciences organisations seeking to accelerate the journey from target discovery to validation. By integrating genomics, multi-omics, and clinical data within a single platform, TargetID reduces research timelines from years to weeks, enabling teams to pinpoint and prioritise high-value drug targets with greater speed and scientific confidence.

Trusted by thousands of researchers across public-sector institutions and enterprises, Lifebit's TargetID Suite automates the most complex steps in target discovery — from variant association analysis through to causal inference — delivering reproducible, auditable results that meet the highest validation standards.

Core Analytical Capabilities

• Variant and Gene Association Analysis: Run large-scale genome-wide association studies (GWAS) to uncover key variants linked to disease across diverse datasets.
• Multi-Ancestry Meta-Analysis: Combine data from diverse populations to increase statistical power and discover novel genetic associations that may be missed in single-ancestry studies.
• Fine-Mapping and Prioritisation: Pinpoint causal variants, prioritise candidate genes, and enrich findings with pathway analysis to focus resources on the most promising targets.
• Functional Annotation and Colocalization: Integrate with expression datasets such as GTEx to assess the functional relevance of variants and identify shared genetic signals across traits.
• Causal Inference and Validation: Apply Mendelian randomisation and other causal inference methods to confirm the biological role of candidate genes and proteins before advancing them in the pipeline.

What Sets TargetID Apart

• Rapid target identification: Automated variant analysis and prioritisation workflows enable researchers to pinpoint high-value genetic and protein targets in days rather than months.
• Multi-omics integration: Seamlessly combine genomics, transcriptomics, proteomics, and clinical data to uncover novel, clinically relevant targets at scale.
• Built for scientific rigour: All workflows are traceable, reproducible, and fully auditable, ensuring every identified target meets stringent validation standards required for drug development.

Enterprise Implementation and Support

• End-to-end implementation tailored to specific research goals and organisational needs.
• Enterprise-grade data security and compliance built into the platform.
• Access to global multi-omics and clinical data integrations to broaden the scope of target discovery.
• 24/7 premium scientific and technical support from Lifebit's expert team.

TargetID is part of Lifebit's broader product suite, which includes a Trusted Research Environment, Trusted Data Factory, Trusted Data Lakehouse, and Trusted Operational Governance tools — enabling organisations to eliminate data silos, unify strategy, and collaborate effectively across the full precision medicine workflow.